Evidence map›Paper›PMID 25935273›Full record

ArticleJournal of vascular surgery2016

Surgical marking pen dye inhibits saphenous vein cell proliferation and migration in saphenous vein graft tissue.

Shinsuke Kikuchi, Richard D Kenagy, Lu Gao, Thomas N Wight, Nobuyoshi Azuma, Michael Sobel, Alexander W Clowes

Open access · greenAbstract read
In one paragraph

Article in Journal of vascular surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Shinsuke KikuchiDepartment of Surgery, University of Washington, Seattle, Wash; Department of Vascular Surgery, Asahikawa Medical University, Asahikawa, Japan.
Richard D KenagyDepartment of Surgery, University of Washington, Seattle, Wash. Electronic address: rkenagy@u.washington.edu.
Lu GaoDepartment of Surgery, University of Washington, Seattle, Wash.
Thomas N WightMatrix Biology Program, Benaroya Research Institute at Virginia Mason, Seattle, Wash.
Nobuyoshi AzumaDepartment of Vascular Surgery, Asahikawa Medical University, Asahikawa, Japan.
Michael SobelDepartment of Surgery, University of Washington, Seattle, Wash; Division of Vascular Surgery, VA Puget Sound Health Care System and University of Washington, Seattle, Wash.
Alexander W ClowesDepartment of Surgery, University of Washington, Seattle, Wash.
University of Washington · USAsahikawa Medical University · JPVirginia Mason Medical Center · US

Funding

MECHANISMS OF ARTERIAL GRAFT HEALINGR01HL030946 · NHLBI · UNIVERSITY OF WASHINGTON · PI SOBEL, MICHAEL · 1985 to 2015
$7.3M
Targeting the Extracellular Matrix to Inhibit Saphenous Vein Graft (SVG) FailureR41HL106967 · NHLBI · MATREXA, LLC · PI WIGHT, THOMAS N · 2011 to 2012
$677k
Preventing Vein Graft Stenosis in Peripheral Vascular SurgeryI01CX000712 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI SOBEL, MICHAEL · 2012 to 2015
–
CSRD VA I01 CX000712NHLBI NIH HHS R01 HL030946NHLBI NIH HHS R01 HL30946NHLBI NIH HHS R41 HL106967
6 · The paper itself

Abstract

objectiveMarkers containing dyes such as crystal violet (CAS 548-62-9) are routinely used on the adventitia of vein bypass grafts to avoid twisting during placement. Because little is known about how these dyes affect vein graft healing and function, we determined the effect of crystal violet on cell migration and proliferation, which are responses to injury after grafting.

methodsFresh human saphenous veins were obtained as residual specimens from leg bypass surgeries. Portions of the vein that had been surgically marked with crystal violet were analyzed separately from those that had no dye marking. In the laboratory, they were split into easily dissected inner and outer layers after removal of endothelium. This cleavage plane was within the circular muscle layer of the media. Cell migration from explants was measured daily as either (1) percentage of migration-positive explants, which exclusively measures migration, or (2) number of cells on the plastic surrounding each explant, which measures migration plus proliferation. Cell proliferation and apoptosis (Ki67 and TUNEL staining, respectively) were determined in dye-marked and unmarked areas of cultured vein rings. The dose-dependent effects of crystal violet were measured for cell migration from explants as well as for proliferation, migration, and death of cultured outer layer cells. Dye was extracted from explants with ethanol and quantified by spectrophotometry.

resultsThere was significantly less cell migration from visibly blue compared with unstained outer layer explants by both methods. There was no significant difference in migration from inner layer explants adjacent to blue-stained or unstained sections of vein because dye did not penetrate to the inner layer. Ki67 staining of vein in organ culture, which is a measure of proliferation, progressively increased up to 6 days in nonblue outer layer and was abolished in the blue outer layer. Evidence of apoptosis (TUNEL staining) was present throughout the wall and not different in blue-stained and unstained vein wall segments. Blue outer layer explants had 65.9 ± 8.0 ng dye/explant compared with 2.1 ± 1.3 for nonblue outer layer explants. Dye applied in vitro to either outer or inner layer explants dose dependently inhibited migration (IC50∼10 ng/explant). The IC50s of crystal violet for outer layer cell proliferation and migration were 0.1 and 1.2 μg/mL, whereas the EC50 for death was between 1 and 10 μg/mL.

conclusionsCrystal violet inhibits venous cell migration and proliferation, indicating that alternative methods should be considered for marking vein grafts.

Indexed as

Surgical EquipmentApoptosisBiomarkersCell MovementCell ProliferationColoring AgentsDose-Response Relationship, DrugEquipment DesignGentian VioletHumansKi-67 AntigenMuscle, Smooth, VascularMyocytes, Smooth MuscleOrgan Culture TechniquesSaphenous VeinTime FactorsBiomarkersColoring AgentsGentian VioletKi-67 Antigen

Identifiers

PMID25935273
PMCPMC4627895
OpenAlexW2071439635

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.